---

---

entities : Amgen inc.   

save search

---

Global Brain Tumor Therapeutics Market (2021 to 2026) - Featuring Amgen, AstraZeneca and NextSource Among Others
Published: 2022-02-18 (Crawled : 22:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K |

Health Technology

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560 |

Health Technology

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| Email alert Add to watchlist
therapeutics train

---

Entera Bio to Present at Aegis Virtual Conference on February 23rd
Published: 2022-02-17 (Crawled : 19:00) - biospace.com/
ENTX | $2.25 1.35% 1.33% 170K |

Health Technology

| 7.51% | O: -1.41% H: 2.14% C: -0.48%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 19.88% | O: -0.53% H: 0.82% C: 0.09%
conference

---

Coherus Names Paul Reider Chief Commercial Officer
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
ABBV | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 14.63% | O: 0.24% H: 1.47% C: 0.98%
CHRS | $1.99 -7.44% -8.04% 1.9M |

Health Technology

| -83.5% | O: 0.77% H: 2.82% C: 0.53%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 19.02% | O: 0.33% H: 0.52% C: -0.47%
commercialization

---

LUMAKRAS® (SOTORASIB) SHOWS ENCOURAGING AND CLINICALLY MEANINGFUL ANTICANCER ACTIVITY IN PATIENTS WITH KRAS G12C-MUTATED ADVANCED PANCREATIC CANCER IN CODEBREAK 100 TRIAL
Published: 2022-02-14 (Crawled : 23:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K |

Health Technology

| -34.71% | O: 4.23% H: 6.03% C: 2.76%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 19.02% | O: 0.33% H: 0.52% C: -0.47%
lumakras trial 100 cancer pancreatic

---

Stroke Therapeutics Market to register a growth of USD 1.54 billion at a CAGR of 5% | High-risk Factors for Stroke is a Key Driver | Technavio
Published: 2022-02-10 (Crawled : 17:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 18.15% | O: -0.35% H: 4.64% C: 1.43%
AMCR | News | $8.9 0.79% 0.0% 5.8M |

Process Industries

| -23.87% | O: 0.09% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -13.6% | O: -0.92% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 19.85% | O: 2.11% H: 3.46% C: 0.76%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 10.83% | O: -2.42% H: 0.49% C: -2.63%
risk therapeutics stroke growth

---

mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published: 2022-02-10 (Crawled : 12:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49 |

Health Technology

| -16.74% | O: -1.72% H: 0.46% C: -0.51%
LZAGY | $57.3 0.02% 33K |

Professional, Scientific, and T...

| -15.39% | O: -1.31% H: 2.63% C: 0.75%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -13.6% | O: -0.92% H: 0.0% C: 0.0%
IONS | $40.81 -0.24% -0.25% 990K |

Health Technology

| 23.78% | O: 0.7% H: 3.82% C: 0.78%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 10.83% | O: -2.42% H: 0.49% C: -2.63%
covid-19 application covid services growing

---

AMGEN PROVIDES LONG-TERM GUIDANCE THROUGH 2030 DURING BUSINESS REVIEW MEETING
Published: 2022-02-08 (Crawled : 14:00) - biospace.com/
BGNE S | $131.94 0.06% 0.06% 130K |

Health Technology

| -39.93% | O: -0.93% H: 0.07% C: -4.48%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 19.76% | O: 4.51% H: 5.06% C: 3.47%

---

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
Published: 2022-02-07 (Crawled : 22:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 210.68% | O: 0.55% H: 0.0% C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 47.73% | O: 1.75% H: 0.71% C: 0.26%
BGNE S | $131.94 0.06% 0.06% 130K |

Health Technology

| -40.09% | O: -0.27% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 20.18% | O: 0.35% H: 0.0% C: 0.0%
financial results report results

---

AMGEN TO HOST VIRTUAL BUSINESS REVIEW MEETING
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 16.88% | O: 0.12% H: 0.15% C: -2.02%

---

AMGEN AND PLEXIUM ANNOUNCE MULTI-YEAR, DRUG DISCOVERY COLLABORATION TO IDENTIFY NOVEL TARGETED PROTEIN DEGRADATION THERAPIES
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
BGNE S | $131.94 0.06% 0.06% 130K |

Health Technology

| -47.72% | O: -5.61% H: 0.0% C: -7.64%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 16.88% | O: 0.12% H: 0.15% C: -2.02%
drug multi-year collaboration drug discovery therapy

---

Heart Failure Drugs Market to Register USD 2.69 billion growth from 2020 to 2025|Technavio
Published: 2022-02-03 (Crawled : 03:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 14.98% | O: -3.25% H: 2.69% C: 2.69%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 9.49% | O: 0.95% H: 0.0% C: -1.36%
NVS | News | $92.57 -0.55% 0.0% 910K |

Health Technology

| 9.35% | O: 1.35% H: 0.67% C: 0.17%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 18.31% | O: -0.21% H: 0.76% C: -0.43%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 16.88% | O: 0.12% H: 0.15% C: -2.02%
heart drug growth

---

Cancer Supportive Care Market Size to Grow by USD 4.98 Billion | Market Research Insights Highlight Growing Prevalence of Cancer Cases as Key Driver | Technavio
Published: 2022-02-01 (Crawled : 05:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 9.19% | O: 3.58% H: 0.0% C: -1.59%
NVS | News | $92.57 -0.55% 0.0% 910K |

Health Technology

| 8.3% | O: 2.5% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -11.61% | O: 0.45% H: 0.53% C: 0.42%
BAX | News | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -53.44% | O: 0.38% H: 0.0% C: -0.77%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -10.86% | O: -0.39% H: 0.24% C: 0.19%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 17.26% | O: -0.22% H: 0.91% C: 0.68%
research cancer growing

---

CuriRx Launches the Advanced Bioprocessing and Analytical Center to Support Biotherapeutic Drug Developers
Published: 2022-01-26 (Crawled : 15:30) - biospace.com/
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 18.62% | O: -1.52% H: 2.4% C: 0.42%
drug iot

---

Cancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research
Published: 2022-01-20 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -10.57% | O: 0.95% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -13.4% | O: 0.06% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -13.84% | O: -1.78% H: 0.0% C: 0.0%
BAX | News | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -53.83% | O: -0.27% H: 2.1% C: 0.27%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 14.2% | O: -0.0% H: 0.0% C: -2.07%
drug research cancer

---

LUMAKRAS® (sotorasib) Receives Approval In Japan For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published: 2022-01-20 (Crawled : 11:00) - biospace.com/
BGNE S | $131.94 0.06% 0.06% 130K |

Health Technology

| -43.81% | O: 3.95% H: 2.8% C: 1.37%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 14.2% | O: -0.0% H: 0.0% C: -2.07%
lumakras approval cel lung cancer cancer

---

Brain Tumor Therapeutics Market to Record 9.10% Y-O-Y Growth Rate in 2021 | Amgen Inc. and Bristol-Myers Squibb Co. Among Key Vendors | Technavio
Published: 2022-01-19 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -13.67% | O: -1.71% H: 0.22% C: -1.8%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 5.54% | O: -0.14% H: 0.0% C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K |

Health Technology

| 4.06% | O: -0.6% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -14.56% | O: -0.84% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 14.03% | O: -0.15% H: 0.0% C: 0.0%
therapeutics growth train

---

Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.Industry Executive Brings More than 20 Years of Clinical Drug Development Expertise
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
IMRX | $1.77 -4.84% -5.08% 180K |

| -85.69% | O: 0.85% H: 3.81% C: -5.42%
ZYME | $8.68 -1.92% -1.96% 730K |

Health Technology

| -40.88% | O: -0.87% H: 1.21% C: -9.77%
BPMC | $88.9 0.59% 0.58% 730K |

Health Technology

| 10.37% | O: -1.6% H: 0.99% C: -4.69%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 15.63% | O: 1.4% H: 0.0% C: 0.0%
drug

---

Osteoporosis Drugs Market - 38% of Growth to Originate from North America |Antiresorptive Drugs Segment to be Significant for Revenue Generation | 17000+ Technavio Reports
Published: 2022-01-18 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 3.48% | O: -1.96% H: 0.0% C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K |

Health Technology

| 2.96% | O: -1.05% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 15.63% | O: 1.4% H: 0.0% C: 0.0%
america drug report growth osteoporosis

---

BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -10.12% | O: -1.67% H: 3.62% C: 3.62%
PPG A | $135.11 0.11% -0.82% 2.3M |

Process Industries

| -20.34% | O: -2.07% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -14.59% | O: -0.53% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -12.87% | O: -0.35% H: 0.0% C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 195.58% | O: -1.46% H: 0.0% C: 0.0%
AMRX | $5.36 -1.83% -1.87% 840K |

Health Technology

| 16.2% | O: -1.71% H: 0.0% C: 0.0%
PHAT | $9.5 -3.06% -3.16% 420K |

Health Technology

| -35.82% | O: -3.08% H: 0.0% C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0 |

Health Technology

| -51.4% | O: -2.14% H: 0.0% C: 0.0%
GILD | $66.16 -1.15% -1.16% 6.4M |

Health Technology

| -7.22% | O: -0.32% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 15.02% | O: -0.53% H: 0.0% C: 0.0%
space spac

---

TEZSPIRE™ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT OF SEVERE ASTHMA
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
BGNE S | $131.94 0.06% 0.06% 130K |

Health Technology

| -46.31% | O: 0.26% H: 0.08% C: -5.65%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 14.85% | O: -0.15% H: 0.0% C: 0.0%
treatment

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---